PORTAIL DOCUMENTAIRE

Article

Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives.

R.B. NESS ; J.A. GRISSO ; J. KLAPPER ; M. MORGAN ; J.J. SCHLESSELMAN ; S. SILBERZWEIG ; R. VERGONA ; J.E. WHEELER ; Center for Clinical Epidemiology and Biostatistics. University of Pennsylvania. Philadelphia. PA. USA ; Graduate School of Public Health. University of Pittsburgh. Pittsburgh. PA. USA ; Share Study Group. INC |

Dans American journal of epidemiology (vol. 152, n° 3, 2000)

[BDSP. Notice produite par INIST Q0FR0xD4. Diffusion soumise à autorisation]. Although past studies have shown that oral contraceptives with 50 mug or more of estrogen reduce the risk of ovarian cancer, it is not clear whether newer, lower-dose [...]

Plus d'information...

Ajouter à ma sélection